Workflow
Fed's Waller says he 'absolutely' would defend US central bank's independence
Reuters· 2025-12-17 16:31
Federal Reserve Governor Christopher Waller, who is on the short list to succeed Fed Chair Jerome Powell next year, said on Wednesday he would "absolutely" defend the central bank's independence if it were challenged by a U.S. president. ...
Why Tesla stock is sliding 3% after hitting new highs earlier in the day
Invezz· 2025-12-17 16:31
Tesla stock came under pressure on Wednesday after touching an all-time high earlier in the session, as investors reacted to fresh regulatory scrutiny in California that could complicate the company's... ...
Gold up, silver soars to record high on safe-haven bids
KITCO· 2025-12-17 16:31
Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another. Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a ...
Can The Trade Desk's OpenPath Transform the Digital Ad Supply Chain?
ZACKS· 2025-12-17 16:30
Key Takeaways TTD is positioning OpenPath to reshape digital ad buying with direct, transparent connections to publishers.OpenPath links directly into trusted auctions, cutting duplication and improving price discovery.TTD says usage has surged, with Hearst seeing higher fill rates and a 23% revenue increase.The Trade Desk, Inc. (TTD) is positioning OpenPath as a transformative force in the digital advertising supply chain, reinforcing its long-standing commitment to transparency, efficiency and advertiser- ...
GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment
ZACKS· 2025-12-17 16:30
Key Takeaways GSK gets FDA nod for Exdensur as an add-on maintenance treatment for severe eosinophilic asthma.Exdensur cut annualized asthma exacerbations versus placebo in phase III SWIFT-1 and SWIFT-2 studies.Exdensur is the first twice-yearly biologic for asthma, while its CRSwNP FDA decision remains pending.GSK plc (GSK) announced that the FDA has approved Exdensur (depemokimab-ulaa), an ultra-long-acting IL-5–targeting biologic, as an add-on maintenance treatment of severe asthma with an eosinophilic p ...
FEIM Stock Up 29% Despite Q2 Earnings Dip Y/Y on Contract Delays
ZACKS· 2025-12-17 16:30
Shares of Frequency Electronics, Inc. (FEIM) have gained 29.2% since the company reported its earnings for the quarter ended Oct. 31, 2025. This compares to the S&P 500 index’s 1.2% decline over the same time frame. Over the past month, the stock has gained 61.4% compared with the S&P 500’s 3.4% growth. The outperformance underscores positive investor sentiment following the company's second-quarter fiscal 2026 results.For the second quarter of fiscal 2026, Frequency Electronics reported a net income of 18 ...
Major franchisee Doherty Enterprises adds Qdoba to its roster
Yahoo Finance· 2025-12-17 16:30
You can find original article here Nrn. Subscribe to our free daily Nrn newsletters. Doherty Enterprises Inc., one of the country’s largest franchisees, is adding Qdoba Mexican Eats to its portfolio with a new agreement to develop 27 restaurants in select New York and New Jersey markets throughout the next several years.  The agreement represents a strategic expansion for Doherty Enterprises, whose portfolio currently includes 158 restaurants across Applebee’s, Panera Bread, Wendy’s, Chevys Fresh M ...
Aspo Plc: Share repurchase 17.12.2025
Globenewswire· 2025-12-17 16:30
Aspo Plc ANNOUNCEMENT 17.12.2025 Aspo Plc: Share repurchase 17.12.2025 In the Helsinki Stock Exchange Trade date 17.12.2025 Bourse trade Buy Share ASPO Amount 1 039SharesAverage price/ share 6,6608EURTotal cost 6 920,57EUR Aspo Plc now holds a ...
New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations
Prnewswire· 2025-12-17 16:30
RICHMOND, Va., Dec. 17, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) today announced results from a randomized, double-blind clinical trial published in JAMA Network Open. The study found that both the 100-mg and 300-mg monthly maintenance doses of SUBLOCADE® (extended- release buprenorphine) rapidly reduced opioid use and improved opioid abstinence and were well tolerated, with no new safety signals in individuals with moderate-to-severe opioid use disorder (OUD). Participants across both dose groups e ...
Options Corner: AMZN Underperforms Mag 7
Youtube· 2025-12-17 16:30
Time now for Options Corner. Joining us to take a deeper look at the chart is Rick Dukat, lead a market technician. All right, so Amazon's been the underperformer within the Mag 7.What trends do you notice. >> Yes, exactly. I mean, they now has the dubious distinction of being the Mag 7's worst performer year to date.Uh Google, Tesla, and Vidia are the top three, by the way. But Amazon only up about 1% versus the S&P up almost 16% on the year and the Mag 7 group up about 19% or so. When we also look at uh A ...